Cargando…

Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging

PURPOSE: Contrast-enhanced magnetic resonance imaging (MRI) has the potential to replace angiographic evaluation of atherosclerosis. While studies have investigated contrast agent (CA) uptake in atherosclerotic plaques, exact CA spatial distribution on a microscale is elusive. The purpose of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Uca, Yavuz Oguz, Hallmann, David, Hesse, Bernhard, Seim, Christian, Stolzenburg, Nicola, Pietsch, Hubertus, Schnorr, Jörg, Taupitz, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099766/
https://www.ncbi.nlm.nih.gov/pubmed/33289060
http://dx.doi.org/10.1007/s11307-020-01563-z
_version_ 1783688641850114048
author Uca, Yavuz Oguz
Hallmann, David
Hesse, Bernhard
Seim, Christian
Stolzenburg, Nicola
Pietsch, Hubertus
Schnorr, Jörg
Taupitz, Matthias
author_facet Uca, Yavuz Oguz
Hallmann, David
Hesse, Bernhard
Seim, Christian
Stolzenburg, Nicola
Pietsch, Hubertus
Schnorr, Jörg
Taupitz, Matthias
author_sort Uca, Yavuz Oguz
collection PubMed
description PURPOSE: Contrast-enhanced magnetic resonance imaging (MRI) has the potential to replace angiographic evaluation of atherosclerosis. While studies have investigated contrast agent (CA) uptake in atherosclerotic plaques, exact CA spatial distribution on a microscale is elusive. The purpose of this study was to investigate the microdistribution of gadolinium (Gd)- and iron (Fe) oxide-based CA in atherosclerotic plaques of New Zealand White rabbits. PROCEDURES: The study was performed as a post hoc analysis of archived tissue specimens obtained in a previous in vivo MRI study conducted to investigate signal changes induced by very small superparamagnetic iron oxide nanoparticles (VSOP) and Gd-BOPTA. For analytical discrimination from endogenous Fe, VSOP were doped with europium (Eu) resulting in Eu-VSOP. Formalin-fixed arterial specimens were cut into 5-μm serial sections and analyzed by immunohistochemistry (IHC: Movat’s pentachrome, von Kossa, and Alcian blue (pH 1.0) staining, anti-smooth muscle cell actin (anti-SMA), and anti-rabbit macrophage (anti-RAM-11) immunostaining) and elemental microscopy with laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and synchrotron radiation μX-ray fluorescence (SR-μXRF) spectroscopy. Elemental distribution maps of Fe, Eu, Gd, sulfur (S), phosphorus (P), and calcium (Ca) were investigated. RESULTS: IHC characterized atherosclerotic plaque pathomorphology. Elemental microscopy showed S distribution to match the anatomy of arterial vessel wall layers, while P distribution corresponded well with cellular areas. LA-ICP-MS revealed Gd and Fe with a limit of detection of ~ 0.1 nmol/g and ~ 100 nmol/g, respectively. Eu-positive signal identified VSOP presence in the vessel wall and allowed the comparison of Eu-VSOP and endogenous Fe distribution in tissue sections. Extracellular matrix material correlated with Eu signal intensity, Fe concentration, and maximum Gd concentration. Eu-VSOP were confined to endothelium in early lesions but accumulated in cellular areas in advanced plaques. Gd distribution was homogeneous in healthy arteries but inhomogeneous in early and advanced plaques. SR-μXRF scans at 0.5 μm resolution revealed Gd hotspots with increased P and Ca concentrations at the intimomedial interface, and a size distribution ranging from a few micrometers to submicrometers. CONCLUSIONS: Eu-VSOP and Gd have distinct spatial distributions in atherosclerotic plaques. While Eu-VSOP distribution is more cell-associated and might be used to monitor atherosclerotic plaque progression, Gd distribution indicates arterial calcification and might help in characterizing plaque vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-020-01563-z.
format Online
Article
Text
id pubmed-8099766
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80997662021-05-11 Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging Uca, Yavuz Oguz Hallmann, David Hesse, Bernhard Seim, Christian Stolzenburg, Nicola Pietsch, Hubertus Schnorr, Jörg Taupitz, Matthias Mol Imaging Biol Research Article PURPOSE: Contrast-enhanced magnetic resonance imaging (MRI) has the potential to replace angiographic evaluation of atherosclerosis. While studies have investigated contrast agent (CA) uptake in atherosclerotic plaques, exact CA spatial distribution on a microscale is elusive. The purpose of this study was to investigate the microdistribution of gadolinium (Gd)- and iron (Fe) oxide-based CA in atherosclerotic plaques of New Zealand White rabbits. PROCEDURES: The study was performed as a post hoc analysis of archived tissue specimens obtained in a previous in vivo MRI study conducted to investigate signal changes induced by very small superparamagnetic iron oxide nanoparticles (VSOP) and Gd-BOPTA. For analytical discrimination from endogenous Fe, VSOP were doped with europium (Eu) resulting in Eu-VSOP. Formalin-fixed arterial specimens were cut into 5-μm serial sections and analyzed by immunohistochemistry (IHC: Movat’s pentachrome, von Kossa, and Alcian blue (pH 1.0) staining, anti-smooth muscle cell actin (anti-SMA), and anti-rabbit macrophage (anti-RAM-11) immunostaining) and elemental microscopy with laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and synchrotron radiation μX-ray fluorescence (SR-μXRF) spectroscopy. Elemental distribution maps of Fe, Eu, Gd, sulfur (S), phosphorus (P), and calcium (Ca) were investigated. RESULTS: IHC characterized atherosclerotic plaque pathomorphology. Elemental microscopy showed S distribution to match the anatomy of arterial vessel wall layers, while P distribution corresponded well with cellular areas. LA-ICP-MS revealed Gd and Fe with a limit of detection of ~ 0.1 nmol/g and ~ 100 nmol/g, respectively. Eu-positive signal identified VSOP presence in the vessel wall and allowed the comparison of Eu-VSOP and endogenous Fe distribution in tissue sections. Extracellular matrix material correlated with Eu signal intensity, Fe concentration, and maximum Gd concentration. Eu-VSOP were confined to endothelium in early lesions but accumulated in cellular areas in advanced plaques. Gd distribution was homogeneous in healthy arteries but inhomogeneous in early and advanced plaques. SR-μXRF scans at 0.5 μm resolution revealed Gd hotspots with increased P and Ca concentrations at the intimomedial interface, and a size distribution ranging from a few micrometers to submicrometers. CONCLUSIONS: Eu-VSOP and Gd have distinct spatial distributions in atherosclerotic plaques. While Eu-VSOP distribution is more cell-associated and might be used to monitor atherosclerotic plaque progression, Gd distribution indicates arterial calcification and might help in characterizing plaque vulnerability. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11307-020-01563-z. Springer International Publishing 2020-12-07 2021 /pmc/articles/PMC8099766/ /pubmed/33289060 http://dx.doi.org/10.1007/s11307-020-01563-z Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Uca, Yavuz Oguz
Hallmann, David
Hesse, Bernhard
Seim, Christian
Stolzenburg, Nicola
Pietsch, Hubertus
Schnorr, Jörg
Taupitz, Matthias
Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title_full Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title_fullStr Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title_full_unstemmed Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title_short Microdistribution of Magnetic Resonance Imaging Contrast Agents in Atherosclerotic Plaques Determined by LA-ICP-MS and SR-μXRF Imaging
title_sort microdistribution of magnetic resonance imaging contrast agents in atherosclerotic plaques determined by la-icp-ms and sr-μxrf imaging
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099766/
https://www.ncbi.nlm.nih.gov/pubmed/33289060
http://dx.doi.org/10.1007/s11307-020-01563-z
work_keys_str_mv AT ucayavuzoguz microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT hallmanndavid microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT hessebernhard microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT seimchristian microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT stolzenburgnicola microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT pietschhubertus microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT schnorrjorg microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging
AT taupitzmatthias microdistributionofmagneticresonanceimagingcontrastagentsinatheroscleroticplaquesdeterminedbylaicpmsandsrmxrfimaging